Drug intelligence / Profile preview

omega-3 fatty acids + inositol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Omega-3 fatty acids + inositol is a combination dietary supplement consisting of two naturally occurring compounds. Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are polyunsaturated fats known for their anti-inflammatory and neuroprotective properties. Inositol is a carbocyclic sugar that plays a role in cell signaling and neurotransmitter modulation. This combination has been studied as an adjunctive or alternative therapy for pediatric bipolar spectrum disorder, with evidence suggesting superior antimanic and antidepressant effects compared to either agent alone[1][2][4][6]. The proposed mechanisms include modulation of neuronal membrane fluidity, neurotransmitter signaling (including serotonin pathways), and possible mood-stabilizing effects. Both components are generally well-tolerated, but more research is needed to confirm efficacy across broader populations.

02

Targets

5-HT (Serotonin receptors)DRD (Dopamine receptors)

Beyond the preview

Go deeper on omega-3 fatty acids + inositol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omega-3 fatty acids + inositol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call